National Biosafety Authority Appoints Dr. Ann Njeri Karimi as Acting Chief Executive Officer
Position
Chief Executive Officer
Company
The National Biosafety Authority (NBA)
NairobiBiotechnologyHealth CareNon ProfitDescription
Dr. Ann Njeri Karimi has been appointed as the Acting Chief Executive Officer of the National Biosafety Authority. Her appointment follows the exit of Nehemiah Ngetich, whose term has ended, and was made effective after a special meeting held on April 2, 2026.
Quick answer
National Biosafety Authority Appoints Dr. Ann Njeri Karimi as Acting Chief Executive Officer (April 3, 2026). The National Biosafety Authority (NBA) is based in Nairobi, Nairobi County, Kenya.
- Who is the new Chief Executive Officer at The National Biosafety Authority (NBA)?
- The National Biosafety Authority (NBA) named Ann Njeri Karimi Chief Executive Officer, announced April 3, 2026.
- What did The National Biosafety Authority (NBA) announce on April 3, 2026?
- Dr. Ann Njeri Karimi has been appointed as the Acting Chief Executive Officer of the National Biosafety Authority. Her appointment follows the exit of Nehemiah Ngetich, whose term has ended, and was made effective after a special meeting held on April 2, 2026.
- What does The National Biosafety Authority (NBA) do?
- The National Biosafety Authority (NBA) was established by the Biosafety Act No. 2 of 2009 to exercise general supervision and control over the transfer, handling and use of genetically modified organisms (GMOs).
- Where is The National Biosafety Authority (NBA) based?
- The National Biosafety Authority (NBA) is based in Nairobi, Nairobi County, Kenya.
- Which similar companies made leadership changes around the same time?
- Rett Syndrome Research Trust (April 1, 2026), UNC Health (April 6, 2026), Research!America (April 7, 2026) and National Comprehensive Cancer Network (April 9, 2026) also announced leadership changes within 45 days of The National Biosafety Authority (NBA).
Source: Fundz verified event record.
Other recent leadership changes in Non Profit and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Rett Syndrome Research Trust Appoints Genevieve Laforet as Chief Medical Officer (April 1, 2026)
- UNC Health Appoints Ernie Bovio as Regional President (April 6, 2026)
- Research!America Appoints Russ Paulsen as President and CEO (April 7, 2026)
- NCCN Appoints Dr. Nancy L. Lewis as Chief Scientific Officer (April 9, 2026)
- NORD Appoints Michael J. Beard as Vice President and Cara Tenenbaum as Director (March 25, 2026)
- American College of Physicians Appoints LeRoi Hicks as CEO (March 23, 2026)
Who to call at The National Biosafety Authority (NBA), and when
A new leader at The National Biosafety Authority (NBA) brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day The National Biosafety Authority (NBA) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at The National Biosafety Authority (NBA), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at The National Biosafety Authority (NBA). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment The National Biosafety Authority (NBA) changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
The National Biosafety Authority (NBA) changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.